Inhibition of HMGB1 Release via Salvianolic Acid B-Mediated SIRT1 Up-Regulation Protects Rats Against Non-Alcoholic Fatty Liver Disease

Scientific Reports - United Kingdom
doi 10.1038/srep16013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Lactobacillus Rhamnosus GG Protects Against Non-Alcoholic Fatty Liver Disease in Mice

PLoS ONE
Multidisciplinary
2014English

Down-Regulation of Nuclear HMGB1 Reduces Ischemia-Induced HMGB1 Translocation and Release and Protects Against Liver Ischemia-Reperfusion Injury

Scientific Reports
Multidisciplinary
2017English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

miR-122 Promotes Hepatic Lipogenesis via Inhibiting the LKB1/AMPK Pathway by Targeting Sirt1 in Non-Alcoholic Fatty Liver Disease

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2019English

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats

Antioxidants
BiochemistryClinical BiochemistryCell BiologyMolecular BiologyPhysiology
2019English

Caveats for the Implementation of Global Strategies Against Non-Alcoholic Fatty Liver Disease

Journal of Hepatology
Hepatology
2020English

Ginsenoside Rg1 Protects Against Non-Alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy